Dr. Gonzalez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1309 E Ridge Road
Suite 1
McAllen, TX 78503Phone+1 956-631-8875Fax+1 956-682-6280
Summary
- Dr. Victor Gonzalez is an ophthalmologist in McAllen, TX and is affiliated with multiple hospitals in the area, including Valley Baptist Medical Center-Harlingen, South Texas Health System, Harlingen Medical Center, Mission Regional Medical Center, Rio Grande Regional Hospital, Knapp Medical Center, and Doctor's Hospital at Renaissance. He received his medical degree from Harvard Medical School and has been in practice 29 years. He specializes in the medical and surgical management of retinal disease and is experienced in diabetes mellitus, glaucoma and related disorder with an expertise in cataract surgery.
Education & Training
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Surgical Retina and Vitreous, 1992 - 1994
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 1989 - 1992
Cedars-Sinai Medical CenterInternship, Internal Medicine, 1988 - 1989
Harvard Medical SchoolClass of 1988
Certifications & Licensure
CA State Medical License 1990 - 2025
TX State Medical License 1994 - 2025- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) Start of enrollment: 2010 Jun 01
- Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control Start of enrollment: 2011 Oct 01
- A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study) Start of enrollment: 2012 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 1726 citationsGlobal Causes of Blindness and Distance Vision Impairment 1990-2020: A Systematic Review and Meta-AnalysisSeth Flaxman, Rupert R A Bourne, Serge Resnikoff, Peter Ackland, Tasanee Braithwaite
The Lancet. Global Health. 2017-12-01 - 226 citationsEarly and Long-Term Responses to Anti–Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I DataVictor H. Gonzalez, Joanna Campbell, Nancy M. Holekamp, Szilard Kiss, Anat Loewenstein
American Journal of Ophthalmology. 2016-12-01 - 103 citationsIdentification of Diabetic Retinopathy Genes through a Genome-Wide Association Study among Mexican-Americans from Starr County, TexasYi-Ping Fu, D. Michael Hallman, Victor H. Gonzalez, Barbara E.K. Klein, Ronald Klein
Journal of Ophthalmology. 2010-09-02
Authored Content
- The Role of Laser for Retinal Vascular Disease in the Anti-VEGF EraApril 2019
Press Mentions
Paladin Phase 4 Study Confirms Safety of Durable ILUVIEN® Treatment and Reduces Burden of Care for DME PatientsJuly 26th, 2022
Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
The Role of Laser for Retinal Vascular Disease in the Anti-VEGF EraApril 1st, 2019- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
